Atai Life Sciences N.V.
ATAI
$1.47
$0.053.52%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 62.33M | 85.92M | 88.35M | 106.25M | 179.26M |
Total Receivables | 1.35M | 6.95M | 12.08M | 2.47M | 2.26M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 772.00K | 1.07M | 59.00K | 660.00K | 1.41M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 15.68M | 20.13M | 17.43M | 8.13M | 2.67M |
Total Current Assets | 80.13M | 114.07M | 117.91M | 117.50M | 185.59M |
|
|||||
Total Current Assets | 80.13M | 114.07M | 117.91M | 117.50M | 185.59M |
Net Property, Plant & Equipment | 3.87M | 1.90M | 1.92M | 2.04M | 2.20M |
Long-term Investments | 331.00K | -- | -- | -- | -- |
Goodwill | 331.00K | -- | -- | -- | -- |
Total Other Intangibles | 3.25M | -- | -- | -- | 1.77M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 850.00K | 2.43M | 2.43M | 26.57M | 12.25M |
Total Assets | 159.39M | 197.52M | 215.78M | 269.12M | 293.48M |
|
|||||
Total Accounts Payable | 2.62M | 4.88M | 3.81M | 3.84M | 4.59M |
Total Accrued Expenses | 9.66M | 11.66M | 12.35M | 9.90M | 14.54M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 9.84M | 2.66M | 239.00K | 244.00K | 275.00K |
Total Finance Division Other Current Liabilities | 2.84M | 439.00K | 1.25M | 1.03M | 715.00K |
Total Other Current Liabilities | 2.84M | 439.00K | 1.25M | 1.03M | 715.00K |
Total Current Liabilities | 24.95M | 19.64M | 17.64M | 15.01M | 20.12M |
|
|||||
Total Current Liabilities | 24.95M | 19.64M | 17.64M | 15.01M | 20.12M |
Long-Term Debt | 16.33M | 22.74M | 20.86M | 21.96M | 20.08M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 732.00K | 808.00K | 838.00K | 907.00K | 990.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 817.00K | 8.02M | 7.91M | 7.99M | 7.98M |
Total Liabilities | 42.83M | 51.20M | 47.25M | 45.86M | 49.16M |
|
|||||
Common Stock & APIC | 834.97M | 827.13M | 822.02M | 819.12M | 813.36M |
Retained Earnings | -700.21M | -661.25M | -634.96M | -577.65M | -550.94M |
Treasury Stock & Other | -18.47M | -20.16M | -19.17M | -18.93M | -19.46M |
Total Common Equity | 116.30M | 145.72M | 167.89M | 222.54M | 242.96M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 116.30M | 145.72M | 167.89M | 222.54M | 242.96M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 257.00K | 596.00K | 643.00K | 713.00K | 1.35M |
Total Equity | 116.55M | 146.32M | 168.53M | 223.26M | 244.32M |
|